While this study demonstrated significantly increased cytosolic Hsp60 levels in active IBD versus healthy controls, this study was performed using immunohistochemistry, immunofluorescence, and Western blotting from tissue samples, which may only be obtained via invasive endoscopy or surgery and thus are not suitable as a source of routine biomarkers. The gene discussed is HSPD1; the disease is inflammatory bowel disease.